​

Mineralys Therapeutics Ownership | Who Owns Mineralys Therapeutics?

OverviewForecastFinancialsChartTranscripts

Mineralys Therapeutics Ownership Summary

Mineralys Therapeutics is owned by 113.93% institutional investors, 1.46% insiders. Proshare advisors is the largest institutional shareholder, holding 0% of MLYS shares.

MLYS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMineralys Therapeutics113.93%1.46%-15.39%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Proshare advisors---
Adams street partners---
Meeder asset management---
Creative planning---
Stempoint capital lp---
Entrypoint capital---
Proficio capital partners---
Ikarian capital---
Geowealth management---
Ronald blue trust---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Proshare advisors---
Adams street partners---
Meeder asset management---
Creative planning---
Stempoint capital lp---
Entrypoint capital---
Proficio capital partners---
Ikarian capital---
Geowealth management---
Ronald blue trust---

Top Buyers

HolderShares% AssetsChange
Ronald blue trust---56.00
Creative planning---77.00
Srs capital advisors---108.00
Meeder asset management---1.34K
Geowealth management---1.44K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---1.61M
Adams street partners---1.13M
Stempoint capital lp---400.10K
Ikarian capital---332.39K
Neos investment management---89.53K

Sold Out

HolderChange
Ronald blue trust-56.00
Creative planning-77.00
Srs capital advisors-108.00
Meeder asset management-1.34K
Geowealth management-1.44K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202515948.60%60,569,32731.79%1131.35%107-28-
Dec 31, 2024109-46,482,607-93-109---
Jun 30, 2024951.06%44,151,0375.44%891.03%6145.24%14-57.58%
Mar 31, 2024946.82%41,871,72920.62%931.01%42-27.59%33120.00%
Dec 31, 20238814.29%34,713,39130.93%952.31%5816.00%1536.36%

Recent Insider Transactions

DateNameRoleActivityValue
May 14, 2025Rodman David Malcom Chief Medical OfficerSell$173.77K
Mar 13, 2025Slingsby Brian Taylor Buy$3.50M
Apr 14, 2025Rodman David Malcom Chief Medical OfficerSell$40.61K
Apr 14, 2025Rodman David Malcom Chief Medical OfficerSell$124.57K
Apr 11, 2025Levy Adam Scott CFO and SecretarySell$129.68K

Insider Transactions Trends

DateBuySell
2025 Q2-8
2025 Q133
2024 Q4-4
2024 Q3-4
2024 Q2-8

MLYS Ownership FAQ

Who Owns Mineralys Therapeutics?

Mineralys Therapeutics shareholders are primarily institutional investors at 113.93%, followed by 1.46% insiders and -15.39% retail investors. The average institutional ownership in Mineralys Therapeutics's industry, Biotech Stocks , is 63.96%, which Mineralys Therapeutics exceeds.

Who owns the most shares of Mineralys Therapeutics?

Mineralys Therapeutics’s largest shareholders are Proshare advisors (0 shares, 0%), Adams street partners (0 shares, 0%), and Meeder asset management (0 shares, 0%). Together, they hold 0% of Mineralys Therapeutics’s total shares outstanding.

Does Blackrock own Mineralys Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Mineralys Therapeutics.

Who is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested?

Proshare advisors is Mineralys Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Mineralys Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools